We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Microfluidic Chambers Advance the Science of Growing Neurons

Researchers at the University of Illinois have developed a method for culturing mammalian neurons in chambers not much larger than the neurons themselves.
News

Codexis Licenses new Drug Metabolite Profiling and Lead Diversification Technology from Caltech

Codexis will incorporate the licensed technology in development of new R&D productivity tools for use by the pharmaceutical industry.
News

Entelos Acquires Iconix Biosciences

Iconix’s technology will add new capabilities for translational medicine and for finding new uses for existing drugs and drug combinations.
News

FDA Approves new Roche West Nile Virus Blood Screening Test

According to Roche, automated test helps ensure safety of blood supply by detecting virus earlier in infection cycle.
News

Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program

Companies will jointly conduct Phase III development and commercialization of DGAT-1 inhibitor compounds.
News

U-M Researchers Dispute Widely Held Ideas About Stem Cells

How do adult stem cells protect themselves from accumulating genetic mutations that can lead to cancer?
News

Leiden University Medical Center Adopts Fluidigm BioMark™ Real-time PCR System

The department of Human Genetics at the University will use biomark dynamic arrays for high-throughput multiplexed analyses.
News

ParagonDx Prepares Molecular Diagnostics Expansion after Acquisition of Gentris Diagnostics

New company will focus on genetic testing market by providing products to enhance medical care by providing early diagnostic information.
News

Philips and the Institute of Health Sciences Join Forces in Molecular Medicine

Royal Philips Electronics and IHS will create new solutions for the early diagnosis of disease and for monitoring the effectiveness of subsequent treatment.
News

Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer Tests

IPSOGEN gains non-exclusive access to Affymetrix microarray technology to develop and market in-vitro diagnostic tests on a worldwide basis.
Advertisement